Effects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Mizuno, Takuro ^a   Mizuno, Shigeru ^b   Kanda, Tsugiyasu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b Mizuno Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; LANINAMIVIR; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR; ANTIVIRUS AGENT; SIALIDASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; JAPAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRESCHOOL CHILD; QUESTIONNAIRE; REAGIN TEST; RECURRENCE RISK; SCHOOL CHILD; THROAT CULTURE; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECTS; ENZYMOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; ORTHOMYXOVIRUS; VACCINATION; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; MALE; MIDDLE AGED; NEURAMINIDASE; ORTHOMYXOVIRIDAE; VACCINATION; YOUNG ADULT; ZANAMIVIR;

EID: 84899074370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092601     Document Type: Article

References (23)

1. Osterholm MT, Kelley NS, Sommer A, Belongia EA (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis.12: 36-44.
2. Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, et al. (2013) 2011-12 seasonal influenza vaccineseffectiveness against confirmed A(H3N2) influenza-hospitalisation: Pooled analysis from a European network of hospitals. A pilot study. PLoS One. 8: e59681.
3. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E (2012) Vaccines for preventing influenza in healthy children. CochraneDatabaseSyst Rev. 15: 8.
4. Louie JK, Yang S, Acosta M, Yen C, Samuel MC, et al. (2012) Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis.55: 1198-1204.
5. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, et al. (2010) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 17: CD004876.
6. Miyamoto A, Watanabe S (2011) Posterior pharyngeal wall follicles as early diagnostic marker for seasonal and novel influenza. Gen Med, 12;51-60.
7. Watanabe A, Chang SC, Kim MJ, Chu DW, Ohashi Y (2010) Long-acting neuraminidase inhibitor laninamiviroctanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial. Clin Infect Dis. 51(10): 1167-75.
8. Vavricka CJ, Li Q, Wu Y, Qi J, Wang M, et al (2011) Structural and functional analysis of laninamivir and its octanoateprodrug reveals group specific mechanisms for influenza NA inhibition. PLoS Pathog. 7: e1002249. doi: 10.1371/journal.ppat.1002249.
9. Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, et al. (2011)Immunoge-Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis. Influenza Other Respi Viruses.5: 299-305.
10. Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, et al. (2012)Clinical effectiveness of neuraminidase inhibitors-oseltamivir, zanamivir, laninamivir, and peramivir-for treatment of influenzaA(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenzaseason in Japan. J Infect Chemother. 18: 858-864.
11. Infectious Agents Surveillance Report (2008) 2007/08 influenza season, Japan. The topic of this month. 29: 297-299.
12. Infectious Agents Surveillance Report (2009) 2008/09 influenza season, Japan. The topic of this month. 30: 285-286.
13. Infectious Agents Surveillance Report (2010) 2009/10 influenza season, Japan. The topic of this month. 31: 248-250.
14. Infectious Agents Surveillance Report (2011) 2010/11 influenza season, Japan. The topic of this month. 32: 314-316.
15. Infectious Disease Surveillance Center, National Institute of Infectious Diseases. Isolation/detection of influenza virus in Japan, 2007-2012. Infectious Agents Surveillance Report. Available: http://www.nih.go.jp/niid/ja/iasr-inf. html.
16. Narwaney KJ, Glanz JM, Norris JM, Fingerlin TE, Hokanson JE, et al. (2013) Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children. Vaccine.31: 1123-1128.
17. Lang PO, Mendes A, Socquet J, Assir N, Govind S, et al. (2012) Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. ClinInterv Aging. 7: 55-64.
18. Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, et al. (2002) Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. ExpGerontol. 37: 427-39. (Pubitemid 34073561)
19. Bresee J, Hayden FG (2013) Epidemic influenza-responding to the expected but unpredictable. N Engl J Med. 368: 589-592.
20. Saito R, Sato I, Suzuki Y, Baranovich T, Matsuda R, et al. (2010) Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation. Pediatr Infect Dis J. 29: 898-904.
21. Huang YC, Lin TY, Wu SL, Tsao KC (2003) Influenza A-associated central nervous system dysfunction in children presenting as transient visual hallucination. Pediatr Infect Dis J. 22: 366-368.
22. Okumura A, Nakano T, Fukumoto Y, Higuchi K, Kamiya H, et al. (2005) Delirious behavior in children with influenza: its clinical features and EEG findings. Brain Dev. 27: 271-274. (Pubitemid 40602868)
23. Dolin R (2012) Harrison's Principles of Internal Medicine. New York: McGraw-Hill Medical Publishing, 1493-1499pp.